Research Article / Open Access
2019; 2(3): 277 – 285. doi: 10.31488/bjcr.131
Allosteric Binding of Wild-Type and E17K Mutant AKT By Resveratrol Compared to AKT Inhibitor III (MK-2206).....
- Tze-chen Hsieh, Dylan John Bennett...
Research Article / Open Access
2019; 2(3): 277 – 285. doi: 10.31488/bjcr.131
AKT is a serine-threonine protein kinase which is hyperactivated in many human cancers....
Research Article / Open Access
2019; 2(3): 286 – 291. doi: 10.31488/bjcr.132
Background: A prospective observational trial was performed to assess whether....
Research Article / Open Access
2019; 2(3): 292 – 297. doi: 10.31488/bjcr.133
Background and Aims: Oral mucositis (OM) is a serious condition that frequently....
Research Article / Open Access
2019; 2(3): 298 – 303. doi: 10.31488/bjcr.134
Background: Checkpoint inhibitors (CPI) are becoming more widely used in a ...
Research Article / Open Access
2019; 2(3): 304 – 307. doi: 10.31488/bjcr.135
Nutritional supplements are widely used among patients with cancer. Recent studies....